MRI surrogates for molecular subgroups of medulloblastoma.

MRI surrogates for molecular subgroups of medulloblastoma.
复制标题

DOI:
10.3174/ajnr.a3990
复制
发表时间:
2014-07
期刊:
AJNR. American journal of neuroradiology
影响因子:
--
通讯作者:
Yeom KW
Yeom KW
中科院分区:
其他
文献类型:
--
作者:
Perreault S;Ramaswamy V;Achrol AS;Chao K;Liu TT;Shih D;Remke M;Schubert S;Bouffet E;Fisher PG;Partap S;Vogel H;Taylor MD;Cho YJ;Yeom KW

文献摘要

被引文献

相似文献

最近发现的髓母细胞瘤分子亚群显示出改善风险分层的潜力。我们假设不同的磁共振成像特征可以预测这些亚群。所有在同一机构诊断为成神经管细胞瘤的患者,包括治疗前磁共振成像和手术组织,作为发现队列(n = 47)。由3名盲法神经放射学家评估MR成像特征。基于纳米串的肿瘤组织检测将肿瘤分为4个已建立的分子亚群(无翅、超音刺猬、3组和4组)。来自独立机构的第二个儿童髓母细胞瘤队列(n = 52)用于验证预测分子亚型的MR成像特征。发现队列的Logistic回归分析显示肿瘤位置(P < 0.001)和增强模式(P = 0.001)是成神经管细胞瘤亚组的重要预测因素。立体特异性计算分析证实,第3组和第4组肿瘤主要发生在第四脑室中线内(100%,P = 0.007),无翼肿瘤定位于小脑脚/小脑桥脑角池,阳性预测值为100% (95% CI, 30%-100%),音刺猬肿瘤出现在小脑半球,阳性预测值为100% (95% CI, 59%-100%)。中线第4组肿瘤表现为轻微/无强化,阳性预测值为91% (95% CI, 59%-98%)。当我们使用基于磁共振成像特征的回归模型时,66%的髓母细胞瘤在发现队列中被正确预测,65%在验证队列中被正确预测。肿瘤位置和增强模式可预测儿童髓母细胞瘤的分子亚群,并可能作为基因组检测的替代指标。
Recently identified molecular subgroups of medulloblastoma have shown potential for improved risk stratification. We hypothesized that distinct MR imaging features can predict these subgroups. All patients with a diagnosis of medulloblastoma at one institution, with both pretherapy MR imaging and surgical tissue, served as the discovery cohort (n = 47). MR imaging features were assessed by 3 blinded neuroradiologists. NanoString-based assay of tumor tissues was conducted to classify the tumors into the 4 established molecular subgroups (wingless, sonic hedgehog, group 3, and group 4). A second pediatric medulloblastoma cohort (n = 52) from an independent institution was used for validation of the MR imaging features predictive of the molecular subtypes. Logistic regression analysis within the discovery cohort revealed tumor location (P < .001) and enhancement pattern (P = .001) to be significant predictors of medulloblastoma subgroups. Stereospecific computational analyses confirmed that group 3 and 4 tumors predominated within the midline fourth ventricle (100%, P = .007), wingless tumors were localized to the cerebellar peduncle/cerebellopontine angle cistern with a positive predictive value of 100% (95% CI, 30%–100%), and sonic hedgehog tumors arose in the cerebellar hemispheres with a positive predictive value of 100% (95% CI, 59%–100%). Midline group 4 tumors presented with minimal/no enhancement with a positive predictive value of 91% (95% CI, 59%–98%). When we used the MR imaging feature–based regression model, 66% of medulloblastomas were correctly predicted in the discovery cohort, and 65%, in the validation cohort. Tumor location and enhancement pattern were predictive of molecular subgroups of pediatric medulloblastoma and may potentially serve as a surrogate for genomic testing.